advertisement
11.4 Prostaglandins (91)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Peace JH
American Journal of Ophthalmology 2015; 160: 266-274.e1
61547 Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting
Kook MS
Japanese Journal of Ophthalmology 2015; 59: 325-334
61046 The use of ocular hypotensive drugs for glaucoma treatment: changing trend in Taiwan from 1997 to 2007
Lin JC
Journal of Glaucoma 2015; 24: 364-371
61498 Prostaglandin Eyedrops Are Associated With Decreased Thicknesses of Eyelid Dermis and Orbicularis Oculi Muscle: Ultrasonographic Findings
Goh AS
Ophthalmic Plastic and Reconstructive Surgery 2016; 32: 337-341
61441 Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials
Tanihara H
JAMA ophthalmology 2015; 133: 755-761
61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Lewis RA
British Journal of Ophthalmology 2016; 100: 339-344
61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Pérez-Roca F
PLoS ONE 2015; 10: e0129419
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Aihara M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Choi DY
Journal of Glaucoma 2016; 25: e56-e57
61752 Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
Quaranta L
Clinical Ophthalmology 2015; 9: 633-643
61137 Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost
Aihara M
Journal of Glaucoma 2016; 25: e610-e614
61590 The Impact of Glaucoma Medications on Corneal Wound Healing
Pinheiro R
Journal of Glaucoma 2016; 25: 122-127
61787 A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients
Fogagnolo P
Advances in Therapy 2015; 32: 356-369
61575 Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost
Krishnamurthy R
British Medical Journal (Clinical Research Edition) Case Reports 2015; 2015:
61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim JH
Korean Journal of Ophthalmology 2015; 29: 270-279
61752 Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
Riva I
Clinical Ophthalmology 2015; 9: 633-643
61394 Effects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative Study
Rodrigo-Morales E
PLoS ONE 2015; 10: e0129419
61329 Effects of Switching from Timolol to Brimonidine in Prostaglandin Analog and Timolol Combination Therapy
Adachi M
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 482-486
61498 Prostaglandin Eyedrops Are Associated With Decreased Thicknesses of Eyelid Dermis and Orbicularis Oculi Muscle: Ultrasonographic Findings
Nassiri N
Ophthalmic Plastic and Reconstructive Surgery 2016; 32: 337-341
61787 A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients
Dipinto A
Advances in Therapy 2015; 32: 356-369
61575 Late postoperative choroidal detachment following an uneventful cataract surgery in a patient on topical latanoprost
Senthil S
British Medical Journal (Clinical Research Edition) Case Reports 2015; 2015:
61535 Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Levy B
British Journal of Ophthalmology 2016; 100: 339-344
61491 In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study
Kim EJ
Korean Journal of Ophthalmology 2015; 29: 270-279
61728 Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension
Ahlberg P
American Journal of Ophthalmology 2015; 160: 266-274.e1
61136 Reversible Conjunctival Pigmentation Associated With Prostaglandin Use
Chang RT
Journal of Glaucoma 2016; 25: e56-e57
